Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 6/20 | 0.61 |
| ▸ | ACE | P12821 | 3/20 | 0.60 |
| ▸ | CPA1 | P15085 | 3/20 | 0.60 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mdl-28170 SCHEMBL30873029 | 1.00 | MME (0.61) | MMEACECPA1ACE2 | |
| Mdl-28170 SCHEMBL11370994 | 1.00 | MME (0.61) | MMEACECPA1ACE2 | |
| SCHEMBL30051551 | 0.97 | MME (0.58) | MMEACECPA1ACE2 | |
| SCHEMBL4322379 | 0.94 | BACE1 (0.58) | MMEACECPA1ACE2 | |
| SCHEMBL4322389 | 0.94 | BACE1 (0.58) | MMEACECPA1ACE2 | |
| SCHEMBL30051124 | 0.94 | BACE1 (0.58) | MMEACECPA1ACE2 | |
| Mdl-28170 SCHEMBL27629989 | 0.94 | MME (0.56) | MMEACECPA1ACE2 | |
| SCHEMBL29575905 | 0.93 | MME (0.55) | MMEACECPA1ACE2 | |
| SCHEMBL29484193 | 0.93 | MME (0.55) | MMEACECPA1ACE2 | |
| SCHEMBL29602011 | 0.93 | MME (0.55) | MMEACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087804-A1 | METHOD FOR PRODUCING SELF-ASSEMBLING DIPEPTIDES | FERTINAGRO BIOTECH, S.L. (ES) | 2026-04-30 | — | — | WO | claimed |
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | HAIKOU QIAOSHUI UNITED TECHNOLOGY CO. LTD. (CN) | 2026-03-12 | — | — | US | claimed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4659591-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | House Foods Group Inc. (JP) | 2025-12-10 | — | — | EP | claimed |
| EP-4659592-A1 | FLAVOR ENHANCING COMPOSITION, MANUFACTURING METHOD THEREFOR, AND METHOD FOR ENHANCING FLAVOR OF FOOD PRODUCT | House Foods Corporation (JP) | 2025-12-10 | — | — | EP | claimed |
| EP-4653020-A1 | TYROSINASE-MEDIATED PROTEIN SITE-SPECIFIC CONJUGATION AND USE THEREOF | Shanghai Shengdi Pharmaceutical Co., Ltd (CN) | 2025-11-26 | — | — | EP | claimed |
| US-20250341515-A1 | METABOLOMIC BIOMARKERS FOR ACUTE KIDNEY INJURY, ASSAYS, COMPOSITIONS AND METHODS OF USE THEREOF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-11-06 | — | — | US | claimed |
| US-12377110-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2025-08-05 | — | — | US | claimed |
| US-20250027938-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-01-23 | — | — | US | claimed |
| WO-2024240064-A1 | ANTIBODY-DRUG CONJUGATE TARGETING ANTIGENIC EPITOPE POLYPEPTIDE, AND USE THEREOF | 贝达药业股份有限公司 | 2024-11-28 | — | — | WO | claimed |
| CN-114845739-A | Drug conjugate of eribulin derivative, preparation method and application thereof in medicine | 上海森辉医药有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-114845740-A | Treatment of cancer | 先天制药公司 | 2022-08-02 | — | — | CN | claimed |
| WO-2022112356-A1 | TREATMENT OF CANCER | INNATE PHARMA (FR) | 2022-06-02 | — | — | WO | claimed |
| EP-3242882-B1 | CGRP ANTAGONIST PEPTIDES | FERRING BV (NL) | 2022-05-04 | — | — | EP | claimed |
| US-20220105050-A1 | PROPOFOL PRODRUG METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2022-04-07 | — | — | US | claimed |
| EP-3805756-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | Metabolon, Inc. (US) | 2021-04-14 | — | — | EP | claimed |
| CN-106537145-B | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2020-08-25 | — | — | CN | claimed |
| CN-106537145-A | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2017-03-22 | — | — | CN | claimed |
| EP-3129909-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | Metabolon, Inc. (US) | 2017-02-15 | — | — | EP | claimed |
| WO-2015157407-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | METABOLON, INC. (US) | 2015-10-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12377110-B2 | Fospropofol methods and compositions | FOS, FOSB, PFAS | MME 2240/4885ACE 573/4885CPA1 2984/4885 |
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | VIP, ANPEP, RNPEP | MME 112/4885ACE 132/4885CPA1 81/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.